Evofem Biosciences, Inc. Quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities in USD for Q3 2023
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Evofem Biosciences, Inc. annual/quarterly Interest Paid, Excluding Capitalized Interest, Operating Activities history and growth rate for Q3 2023.
- Evofem Biosciences, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending October 1, 2023 was $500K.
- Evofem Biosciences, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $338K, a 51.6% decline from 2022.
- Evofem Biosciences, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $698K, a 49.7% decline from 2021.
- Evofem Biosciences, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2021 was $1.39M.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)